Dyne Therapeutics (DYN) PT Raised to $35 at RBC Capital
Tweet
Share
E-mailGet Alerts DYN Hot Sheet
Price: $15.97 -1.6%
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 48
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 48
Join SI Premium – FREE
RBC Capital analyst Luca Issi raised the price target on Dyne Therapeutics (NASDAQ: DYN) to $35.00 (from $30.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Okta, Inc (OKTA) PT Raised to $235 at DA Davidson Following Oktane 2026
- Alight Solutions (ALIT) PT Lowered to $22 at DA Davidson on Customer Attrition Impact
- Canadian National Railway (CNR:CN) (CNR) PT Lowered to Cdn$198 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
